Investor directory

Alger

Fred Alger Management is an asset management firm based in New York City, founded in 1964. It specializes in managing client-focused equity portfolios and mutual funds, offering services primarily to individual investors as well as investment companies, pension plans, charitable organizations, corporations, and government entities. The firm invests in public equity and fixed income markets worldwide, focusing on growth stocks across small-cap, mid-cap, and large-cap companies. Utilizing a bottom-up stock picking approach, Alger employs fundamental analysis and in-house research to construct its investment portfolios. Additionally, the firm has an office in Jersey City, New Jersey, and operates as a subsidiary of Fred Alger & Company Incorporated.
http://www.alger.com
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=2033483

James Blakeslee

Senior Vice President and Director of National Accounts

Daniel C. Chung

CEO, Chief Investment Officer, Portfolio Manager

Dennis Hearns

Senior Vice President and Co-Head of Intermediary Distribution

Christopher Walsh

Senior Vice President, Senior Analyst and Portfolio Manager

Alexander Xethalis

Vice President

Past deals in New Jersey

Impulse Dynamics

Venture Round in 2024
Impulse Dynamics N.V. is a medical device company that specializes in developing innovative electrical therapies for chronic heart failure. Founded in 1996 and headquartered in Willemstad, Curacao, the company also maintains offices in New York and Hong Kong, with product development centers located in New Jersey and Israel. Its primary offering, the CCM® therapy, utilizes cardiac contractility modulation technology to deliver non-excitatory electrical impulses to the heart, enhancing its contraction and improving blood flow to the body. This minimally invasive treatment option addresses the needs of heart failure patients who have limited alternatives. Impulse Dynamics conducts clinical trials to assess the safety and efficacy of its therapies and collaborates with universities and hospitals for ongoing research and development.

Impulse Dynamics

Venture Round in 2022
Impulse Dynamics N.V. is a medical device company that specializes in developing innovative electrical therapies for chronic heart failure. Founded in 1996 and headquartered in Willemstad, Curacao, the company also maintains offices in New York and Hong Kong, with product development centers located in New Jersey and Israel. Its primary offering, the CCM® therapy, utilizes cardiac contractility modulation technology to deliver non-excitatory electrical impulses to the heart, enhancing its contraction and improving blood flow to the body. This minimally invasive treatment option addresses the needs of heart failure patients who have limited alternatives. Impulse Dynamics conducts clinical trials to assess the safety and efficacy of its therapies and collaborates with universities and hospitals for ongoing research and development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.